Stem cells, growth factors and scaffolds in craniofacial regenerative medicine

Schmitz, 1986, The critical size defect as an experimental model for craniomandibulofacial nonunions, Clin Orthop, 205, 299, 10.1097/00003086-198604000-00036 Van Aalst, 2005, Surgical technique for primary alveolar bone grafting, J Craniofac Surg, 16, 706, 10.1097/01.SCS.0000157311.85161.E8 Engstrand, 2014, Development of a bioactive implant for repair and potential healing of cranial defects, J Neurosurg, 120, 273, 10.3171/2013.6.JNS1360 Misch, 2010, Autogenous bone: is it still the gold standard?, Implant Dent, 19, 361, 10.1097/ID.0b013e3181f8115b Banwart, 1995, Iliac crest bone graft harvest donor site morbidity. A statistical evaluation, Spine, 20, 1055, 10.1097/00007632-199505000-00012 Mangano, 2015, Custom-made computer-aided-design/computer-aided-manufacturing biphasic calcium-phosphate scaffold for augmentation of an atrophic mandibular anterior ridge, Case Rep Dent, 2015, e941265 Rosenthal, 2003, Volume maintenance of inlay bone grafts in the craniofacial skeleton, Plast Reconstr Surg, 112, 802, 10.1097/01.PRS.0000069713.62687.F5 Acarturk, 2006, Commercially available demineralized bone matrix compositions to regenerate calvarial critical-sized bone defects, Plast Reconstr Surg, 118, 862, 10.1097/01.prs.0000232385.81219.87 Smartt, 2005, Repair of the immature and mature craniofacial skeleton with a carbonated calcium phosphate cement: assessment of biocompatibility, osteoconductivity, and remodeling capacity, Plast Reconstr Surg, 115, 1642, 10.1097/01.PRS.0000161466.74294.1E Gosain, 1999, Biomaterials in the face: benefits and risks, J Craniofac Surg, 10, 404, 10.1097/00001665-199909000-00006 Sargent, 1991, Reconstruction of internal orbital fractures with vitallium mesh, Plast Reconstr Surg, 88, 31, 10.1097/00006534-199107000-00006 Hurvitz, 2006, Current options in head and neck reconstruction, Plast Reconstr Surg, 118, 122e, 10.1097/01.prs.0000237094.58891.fb Tevlin, 2014, Biomaterials for craniofacial bone engineering, J Dent Res, 93, 1187, 10.1177/0022034514547271 Fishero, 2015, Current concepts of bone tissue engineering for craniofacial bone defect repair, Craniomaxillofacial Trauma Reconstr, 8, 23, 10.1055/s-0034-1393724 Fu, 2014, Potential replication of induced pluripotent stem cells for craniofacial reconstruction, Curr Stem Cell Res Ther, 9, 205, 10.2174/1574888X09666140213155800 Zaidi, 2007, Stem cell therapy in bone repair and regeneration, Ann N. Y Acad Sci, 1117, 62, 10.1196/annals.1402.074 Albrektsson, 2001, Osteoinduction, osteoconduction and osseointegration, Eur Spine J Off Publ Eur Spine Soc Eur Spinal Deform Soc Eur Sect Cerv Spine Res Soc, 10, S96 Zaky, 2009, Engineering craniofacial structures: facing the challenge, J Dent Res, 88, 1077, 10.1177/0022034509349926 Kunert-Keil, 2015, Comparative study of biphasic calcium phosphate with beta-tricalcium phosphate in rat cranial defects—A molecular-biological and histological study, Ann Anat Anat Anz, 199, 79, 10.1016/j.aanat.2013.12.001 Zhao, 2006, Electrical signals control wound healing through phosphatidylinositol-3-OH kinase-gamma and PTEN, Nature, 442, 457, 10.1038/nature04925 McAllister, 2007, Bone augmentation techniques, J Periodontol, 78, 377, 10.1902/jop.2007.060048 Meijer, 2008, Cell based bone tissue engineering in jaw defects, Biomaterials, 29, 3053, 10.1016/j.biomaterials.2008.03.012 Gimbel, 2007, Repair of alveolar cleft defects: reduced morbidity with bone marrow stem cells in a resorbable matrix, J Craniofac Surg, 18, 895, 10.1097/scs.0b013e3180a771af McAllister, 2009, Histologic evaluation of a stem cell-based sinus-augmentation procedure, J Periodontol, 80, 679, 10.1902/jop.2009.080345 Sándor, 2014, Adipose stem cells used to reconstruct 13 cases with cranio-maxillofacial hard-tissue defects, Stem Cells Transl Med, 3, 530, 10.5966/sctm.2013-0173 Mendonça, 2010, Regenerative facial reconstruction of terminal stage osteoradionecrosis and other advanced craniofacial diseases with adult cultured stem and progenitor cells, Plast Reconstr Surg, 126, 1699, 10.1097/PRS.0b013e3181f24164 Zamiri, 2013, Reconstruction of human mandibular continuity defects with allogenic scaffold and autologous marrow mesenchymal stem cells, J Craniofac Surg, 24, 1292, 10.1097/SCS.0b013e318294288a Yamada, 2013, Injectable bone tissue engineering using expanded mesenchymal stem cells, Stem Cells Dayt Ohio, 31, 572, 10.1002/stem.1300 Behnia, 2012, Repair of alveolar cleft defect with mesenchymal stem cells and platelet derived growth factors: a preliminary report, J Cranio-Maxillo-Fac Surg Off Publ Eur Assoc Cranio-Maxillo-Fac Surg, 40, 2, 10.1016/j.jcms.2011.02.003 Rickert, 2011, Maxillary sinus floor elevation with bovine bone mineral combined with either autogenous bone or autogenous stem cells: a prospective randomized clinical trial, Clin Oral Implants Res, 22, 251, 10.1111/j.1600-0501.2010.01981.x Shayesteh, 2008, Sinus augmentation using human mesenchymal stem cells loaded into a beta-tricalcium phosphate/hydroxyapatite scaffold, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 106, 203, 10.1016/j.tripleo.2007.12.001 Ueda, 2005, Clinical case reports of injectable tissue-engineered bone for alveolar augmentation with simultaneous implant placement, Int J Periodontics Restor Dent, 25, 129 Levi, 2010, Human adipose derived stromal cells heal critical size mouse calvarial defects, PLoS One, 5, e11177, 10.1371/journal.pone.0011177 Chung, 2012, CD90 (Thy-1)-Positive selection enhances osteogenic capacity of human adipose-derived stromal cells, Tissue Eng Part A, 19, 989, 10.1089/ten.tea.2012.0370 Kaigler, 2015, Bone engineering of maxillary sinus bone deficiencies using enriched CD90+ stem cell therapy: a randomized clinical trial, J Bone Min Res Off J Am Soc Bone Min Res, 30, 1206, 10.1002/jbmr.2464 Urbich, 2003, Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells, Circulation, 108, 2511, 10.1161/01.CIR.0000096483.29777.50 Caballero, 2015, Juvenile swine surgical alveolar cleft model to test novel autologous stem cell therapies, Tissue Eng Part C Methods, 21, 898, 10.1089/ten.tec.2014.0646 Guan, 2015, Human urine-derived stem cells can be induced into osteogenic lineage by silicate bioceramics via activation of the Wnt/β-catenin signaling pathway, Biomaterials, 55, 1, 10.1016/j.biomaterials.2015.03.029 Strem, 2005, Multipotential differentiation of adipose tissue-derived stem cells, Keio J Med, 54, 132, 10.2302/kjm.54.132 Liao, 2014, Osteogenic differentiation of adipose-derived stem cells and calvarial defect repair using baculovirus-mediated co-expression of BMP-2 and miR-148b, Biomaterials, 35, 4901, 10.1016/j.biomaterials.2014.02.055 Guan, 2015, Bone morphogenetic protein 2 gene transduction enhances the osteogenic potential of human urine-derived stem cells, Stem Cell Res Ther, 6, 5, 10.1186/scrt539 Guan, 2015, Human urine derived stem cells in combination with β-tcp can be applied for bone regeneration, PloS One, 10, e0125253, 10.1371/journal.pone.0125253 Guan, 2014, Biological characteristics of human-urine-derived stem cells: potential for cell-based therapy in neurology, Tissue Eng Part A, 20, 1794, 10.1089/ten.tea.2013.0584 Eldesoqi, 2013, High calcium bioglass enhances differentiation and survival of endothelial progenitor cells, inducing early vascularization in critical size bone defects, PloS One, 8, e79058, 10.1371/journal.pone.0079058 He, 2013, BMP2 genetically engineered MSCs and EPCs promote vascularized bone regeneration in rat critical-sized calvarial bone defects, PloS One, 8, e60473, 10.1371/journal.pone.0060473 Seebach, 2012, Endothelial progenitor cells improve directly and indirectly early vascularization of mesenchymal stem cell-driven bone regeneration in a critical bone defect in rats, Cell Transpl, 21, 1667, 10.3727/096368912X638937 Cillo, 2000, Growth factor and cytokine gene expression in mechanically strained human osteoblast-like cells: implications for distraction osteogenesis, Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology, 90, 147, 10.1067/moe.2000.107531 Wallner, 2015, Application of VEGFA and FGF-9 enhances angiogenesis, osteogenesis and bone remodeling in type 2 diabetic long bone regeneration, PloS One, 10, e0118823, 10.1371/journal.pone.0118823 Al-Zube, 2009, Recombinant human platelet-derived growth factor BB (rhPDGF-BB) and beta-tricalcium phosphate/collagen matrix enhance fracture healing in a diabetic rat model, J Orthop Res Off Publ Orthop Res Soc, 27, 1074, 10.1002/jor.20842 Li, 2014, PDGF-AA promotes osteogenic differentiation and migration of mesenchymal stem cell by down-regulating PDGFRα and derepressing BMP-Smad1/5/8 signaling, PLoS One, 9 Dickinson, 2008, Reduced morbidity and improved healing with bone morphogenic protein-2 in older patients with alveolar cleft defects, Plast Reconstr Surg, 121, 209, 10.1097/01.prs.0000293870.64781.12 Yuan, 2012, Biomimetic scaffolds: implications for craniofacial regeneration, J Craniofac Surg, 23, 294, 10.1097/SCS.0b013e318241bae1 Hong, 2013, Enhancement of bone consolidation in mandibular distraction osteogenesis: a contemporary review of experimental studies involving adjuvant therapies, J Plast Reconstr Aesthet Surg, 66, 883, 10.1016/j.bjps.2013.03.030 Krebsbach, 2000, Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo, Hum Gene Ther, 11, 1201, 10.1089/10430340050015248 Riew, 1998, Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model, Calcif Tissue Int, 63, 357, 10.1007/s002239900540 Sandhu, 2001, Demineralized bone matrix, bone morphogenetic proteins, and animal models of spine fusion: an overview, Eur Spine J Off Publ Eur Spine Soc Eur Spinal Deform Soc Eur Sect Cerv Spine Res Soc, 10, S122 Varady, 2001, Morphologic analysis of BMP-9 gene therapy-induced osteogenesis, Hum Gene Ther, 12, 697, 10.1089/104303401300057423 Bostrom, 1998, Potential role of bone morphogenetic proteins in fracture healing, Clin Orthop, 355, S274, 10.1097/00003086-199810001-00028 Cheng, 2001, In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene, Calcif Tissue Int, 68, 87, 10.1007/BF02678146 Gerhart, 1993, Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein, Clin Orthop, 293, 317 Heckman, 1991, The use of bone morphogenetic protein in the treatment of non-union in a canine model, J Bone Jt Surg Am, 73, 750, 10.2106/00004623-199173050-00015 Helm, 2000, Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent, J Neurosurg, 92, 191 Lee, 1994, Translational energy spectra for single-electron capture by O2+ in He, Ne, and Ar, Phys Rev A, 50, 1149, 10.1103/PhysRevA.50.1149 Partridge, 2002, Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds, Biochem Biophys Res Commun, 292, 144, 10.1006/bbrc.2002.6623 Varady, 2002, CT and radionuclide study of BMP-2 gene therapy-induced bone formation, Acad Radiol, 9, 632, 10.1016/S1076-6332(03)80307-0 Lamplot, 2013, BMP9 signaling in stem cell differentiation and osteogenesis, Am J Stem Cells, 2, 1 Luu, 2007, Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells, J Orthop Res Off Publ Orthop Res Soc, 25, 665, 10.1002/jor.20359 Deng, 2008, Regulation of osteogenic differentiation during skeletal development, Front Biosci J Virtual Libr, 13, 2001, 10.2741/2819 Ducy, 2000, The family of bone morphogenetic proteins, Kidney Int, 57, 2207, 10.1046/j.1523-1755.2000.00081.x Kang, 2009, A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells, Stem Cells Dev, 18, 545, 10.1089/scd.2008.0130 Luo, 2005, Gene therapy for bone regeneration, Curr Gene Ther, 5, 167, 10.2174/1566523053544218 Reddi, 1998, Role of morphogenetic proteins in skeletal tissue engineering and regeneration, Nat Biotechnol, 16, 247, 10.1038/nbt0398-247 Shi, 2003, Mechanisms of TGF-beta signaling from cell membrane to the nucleus, Cell, 113, 685, 10.1016/S0092-8674(03)00432-X Tang, 2008, Osteosarcoma development and stem cell differentiation, Clin Orthop, 466, 2114, 10.1007/s11999-008-0335-z Wagner, 2010, Therapeutic implications of PPAR gamma in human osteosarcoma, PPAR Res, 2010, 956427, 10.1155/2010/956427 Cahill, 2009, Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures, JAMA, 302, 58, 10.1001/jama.2009.956 Aghaloo, 2007, A study of the role of nell-1 gene modified goat bone marrow stromal cells in promoting new bone formation, Mol Ther J Am Soc Gene Ther, 15, 1872, 10.1038/sj.mt.6300270 Chen, 2010, Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion, J Neurosurg Spine, 12, 40, 10.3171/2009.4.SPINE0876 Perri, 2007, Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study, Spine J Off J North Am Spine Soc, 7, 235, 10.1016/j.spinee.2006.04.010 Issa, 2008, Sustained release carriers used to delivery bone morphogenetic proteins in the bone healing process, Anat Histol Embryol, 37, 181, 10.1111/j.1439-0264.2007.00824.x Cao, 2014, Vascularization and bone regeneration in a critical sized defect using 2-N, 6-O-sulfated chitosan nanoparticles incorporating BMP-2, Biomaterials, 35, 684, 10.1016/j.biomaterials.2013.10.005 Amini, 2012, Bone tissue engineering: recent advances and challenges, Crit Rev Biomed Eng, 40, 363, 10.1615/CritRevBiomedEng.v40.i5.10 Scheller, 2009, Gene therapy: design and prospects for craniofacial regeneration, J Dent Res, 88, 585, 10.1177/0022034509337480 Scheller, 2012, Gene therapy: implications for craniofacial regeneration, J Craniofac Surg, 23, 333, 10.1097/SCS.0b013e318241dc11 Zisch, 2003, Cell-demanded release of VEGF from synthetic, biointeractive cell-ingrowth matrices for vascularized tissue growth, FASEB J, 17, 2260, 10.1096/fj.02-1041fje Ehrbar, 2004, Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth, Circ Res, 94, 1124, 10.1161/01.RES.0000126411.29641.08 Fong, 2003, New strategies for craniofacial repair and replacement: a brief review, J Craniofac Surg, 14, 333, 10.1097/00001665-200305000-00011 Laurencin, 2014, Delivery of small molecules for bone regenerative engineering: preclinical studies and potential clinical applications, Drug Discov Today, 19, 794, 10.1016/j.drudis.2014.01.012 Mundy, 1999, Stimulation of bone formation in vitro and in rodents by statins, Science, 286, 1946, 10.1126/science.286.5446.1946 Zhou, 2010, The role of simvastatin in the osteogenesis of injectable tissue-engineered bone based on human adipose-derived stromal cells and platelet-rich plasma, Biomaterials, 31, 5325, 10.1016/j.biomaterials.2010.03.037 Dai, 2008, Stimulation of osteogenic activity in mesenchymal stem cells by FK506, J Biomed Mater Res A, 86, 235, 10.1002/jbm.a.31685 Isomoto, 2007, Rapamycin as an inhibitor of osteogenic differentiation in bone marrow-derived mesenchymal stem cells, J Orthop Sci Off J Jpn Orthop Assoc, 12, 83 Park, 2009, The small molecule phenamil induces osteoblast differentiation and mineralization, Mol Cell Biol, 29, 3905, 10.1128/MCB.00002-09 Lo, 2014, Evaluating the feasibility of utilizing the small molecule phenamil as a novel biofactor for bone regenerative engineering, J Tissue Eng Regen Med, 8, 728, 10.1002/term.1573 Kim, 2013, Stimulating effects of quercetin and phenamil on differentiation of human dental pulp cells, Eur J Oral Sci, 121, 559, 10.1111/eos.12086 Lo, 2013, Short-term administration of small molecule phenamil induced a protracted osteogenic effect on osteoblast-like MC3T3-E1 cells, J Tissue Eng Regen Med Fan, 2015, Delivery of phenamil enhances BMP-2-induced osteogenic differentiation of adipose-derived stem cells and bone formation in calvarial defects, Tissue Eng Part A, 21, 2053, 10.1089/ten.tea.2014.0489 Marsell, 2011, The biology of fracture healing, Injury, 42, 551, 10.1016/j.injury.2011.03.031 Tuli, 1978, The osteoninductive property of decalcified bone matrix. An experimental study, J Bone Jt Surg Br, 60, 116, 10.1302/0301-620X.60B1.342532 Bucholz, 1987, Hydroxyapatite and tricalcium phosphate bone graft substitutes, Orthop Clin North Am, 18, 323, 10.1016/S0030-5898(20)30395-3 Gentili, 2009, Cartilage and bone extracellular matrix, Curr Pharm Des, 15, 1334, 10.2174/138161209787846739 Engler, 2006, Matrix elasticity directs stem cell lineage specification, Cell, 126, 677, 10.1016/j.cell.2006.06.044 Graziano, 2008, Scaffold's surface geometry significantly affects human stem cell bone tissue engineering, J Cell Physiol, 214, 166, 10.1002/jcp.21175 Cornell, 1992, Newest factors in fracture healing, Clin Orthop, 277, 297, 10.1097/00003086-199204000-00036 Petrovic, 2012, Craniofacial bone tissue engineering, Oral Surg Oral Med Oral Pathol Oral Radiol, 114, e1, 10.1016/j.oooo.2012.02.030 Hyun, 2013, Enhancing stem cell survival in vivo for tissue repair, Biotechnol Adv, 31, 736, 10.1016/j.biotechadv.2012.11.003 Liu, 2011, Real-time in vivo detection of biomaterial-induced reactive oxygen species, Biomaterials, 32, 1796, 10.1016/j.biomaterials.2010.11.029 Fu, 2000, Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres, Pharm Res, 17, 100, 10.1023/A:1007582911958 Krifka, 2013, A review of adaptive mechanisms in cell responses towards oxidative stress caused by dental resin monomers, Biomaterials, 34, 4555, 10.1016/j.biomaterials.2013.03.019 Loor, 2010, Menadione triggers cell death through ROS-dependent mechanisms involving PARP activation without requiring apoptosis, Free Radic Biol Med, 49, 1925, 10.1016/j.freeradbiomed.2010.09.021 Manke, 2013, Mechanisms of nanoparticle-induced oxidative stress and toxicity, Biomed Res Int, 2013, e942916, 10.1155/2013/942916 Tikekar, 2013, “Click chemistry” based conjugation of lipophilic curcumin to hydrophilic ε-polylysine for enhanced functionality, Food Res Int, 54, 44, 10.1016/j.foodres.2013.06.004 Ren, 2013, Phenolic antioxidants-functionalized quaternized chitosan: synthesis and antioxidant properties, Int J Biol Macromol, 53, 77, 10.1016/j.ijbiomac.2012.11.011 Dobrun, 2012, Molecular characteristics and antioxidant activity of polyethylene glycols modified by sterically hindered phenols, J Struct Chem, 52, 1161, 10.1134/S0022476611060229 Spizzirri, 2011, Innovative antioxidant thermo-responsive hydrogels by radical grafting of catechin on inulin chain, Carbohydr Polym, 84, 517, 10.1016/j.carbpol.2010.12.015 Yang, 2014, A thermoresponsive biodegradable polymer with intrinsic antioxidant properties, Biomacromolecules, 15, 3942, 10.1021/bm5010004 Arun Kumar, 2015, Injectable chitin-poly(ε-caprolactone)/nanohydroxyapatite composite microgels prepared by simple regeneration technique for bone tissue engineering, ACS Appl Mater Interfaces, 7, 9399, 10.1021/acsami.5b02685 Yuan, 2001, Bone formation induced by calcium phosphate ceramics in soft tissue of dogs: a comparative study between porous α-TCP and β-TCP, J Mater Sci Mater Med, 12, 7, 10.1023/A:1026792615665 Kuemmerle, 2005, Assessment of the suitability of a new brushite calcium phosphate cement for cranioplasty—an experimental study in sheep, J Cranio-Maxillo-Fac Surg Off Publ Eur Assoc Cranio-Maxillo-Fac Surg, 33, 37, 10.1016/j.jcms.2004.09.002 Habibovic, 2006, Osteoinduction by biomaterials—physicochemical and structural influences, J Biomed Mater Res A, 77A, 747, 10.1002/jbm.a.30712 Ward, 2010, Bioengineering strategies for regeneration of craniofacial bone: a review of emerging technologies, Oral Dis, 16, 709, 10.1111/j.1601-0825.2010.01682.x Wang, 2011, Progenitor cell mobilization enhances bone healing by means of improved neovascularization and osteogenesis, Plast Reconstr Surg, 128, 395, 10.1097/PRS.0b013e31821e6e10 Nomi, 2006, Role of growth factors and endothelial cells in therapeutic angiogenesis and tissue engineering, Curr Stem Cell Res Ther, 1, 333, 10.2174/157488806778226777 Lovett, 2009, Vascularization strategies for tissue engineering, Tissue Eng Part B Rev, 15, 353, 10.1089/ten.teb.2009.0085 Yang, 2007, Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction, Cardiology, 107, 17, 10.1159/000093609 Mark von der, 2009, Nanoscale engineering of biomimetic surfaces: cues from the extracellular matrix, Cell Tissue Res, 339, 131, 10.1007/s00441-009-0896-5 Conconi, 2010, Effects on in vitro and in vivo angiogenesis induced by small peptides carrying adhesion sequences, J Pept Sci, 16, 349 Kaigler, 2010, Angiogenic and osteogenic potential of bone repair cells for craniofacial regeneration, Tissue Eng Part A, 16, 2809, 10.1089/ten.tea.2010.0079 Warnke, 2004, Growth and transplantation of a custom vascularised bone graft in a man, Lancet, 364, 766, 10.1016/S0140-6736(04)16935-3 McDowell, 1978, Plastic surgery in the twentieth century, Ann Plast Surg, 1, 217, 10.1097/00000637-197803000-00012 Kusumbe, 2014, Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone, Nature, 507, 323, 10.1038/nature13145 Hollister, 2005, Porous scaffold design for tissue engineering, Nat Mater, 4, 518, 10.1038/nmat1421 Muschler, 2004, Engineering principles of clinical cell-based tissue engineering, J Bone Jt Surg Am, 86-A, 1541, 10.2106/00004623-200407000-00029 Adachi, 2006, Framework for optimal design of porous scaffold microstructure by computational simulation of bone regeneration, Biomaterials, 27, 3964, 10.1016/j.biomaterials.2006.02.039 Jones, 2007, Assessment of bone ingrowth into porous biomaterials using MICRO-CT, Biomaterials, 28, 2491, 10.1016/j.biomaterials.2007.01.046 Mao, 2006, Craniofacial tissue engineering by stem cells, J Dent Res, 85, 966, 10.1177/154405910608501101 Mitchell, 1998, Radiation-induced changes in bone, Radiogr Rev Publ Radiol Soc N Am Inc, 18, 1125 Spear, 1999, Tolerance of autologous and allogeneic bone grafts to therapeutic radiation in humans, Int J Radiat Oncol Biol Phys, 45, 1275, 10.1016/S0360-3016(99)00339-9 Okunieff, 1998, In vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice, Radiat Res, 150, 204, 10.2307/3579856 Okunieff, 1998, Radiation-induced changes in bone perfusion and angiogenesis, Int J Radiat Oncol Biol Phys, 42, 885, 10.1016/S0360-3016(98)00339-3 Nussenbaum, 2005, Bone regeneration in cranial defects previously treated with radiation, Laryngoscope, 115, 1170, 10.1097/01.MLG.0000166513.74247.CC Nussenbaum, 2003, Ex vivo gene therapy for skeletal regeneration in cranial defects compromised by postoperative radiotherapy, Hum Gene Ther, 14, 1107, 10.1089/104303403322124819 Ceramic and non-ceramic hydroxyapatite as a bone graft material: a brief review–Springer. Mantripragada, 2013, An overview of recent advances in designing orthopedic and craniofacial implants, J Biomed Mater Res A, 101, 3349 Preparation of porous PLA/DBM composite biomaterials and experimental research of repair rabbit radius segmental bone defect–Springer. B, 2013, Demineralized dentin matrix and bone graft: a review of literature, J West Soc Periodontol Abstr, 62, 35 Plum, 2015, A comparison between autograft alone, bone cement, and demineralized bone matrix in cranioplasty, Laryngoscope, 125, 1322, 10.1002/lary.25158 Schwartz, 1999, Biphasic synthetic bone substitute use in orthopaedic and trauma surgery: clinical, radiological and histological results, J Mater Sci Mater Med, 10, 821, 10.1023/A:1008944227417 Nihouannen, 2007, Interactions of total bone marrow cells with increasing quantities of macroporous calcium phosphate ceramic granules, J Mater Sci Mater Med, 18, 1983, 10.1007/s10856-007-3098-2 Walsh, 2008, β-TCP bone graft substitutes in a bilateral rabbit tibial defect model, Biomaterials, 29, 266, 10.1016/j.biomaterials.2007.09.035 Cancedda, 2007, A tissue engineering approach to bone repair in large animal models and in clinical practice, Biomaterials, 28, 4240, 10.1016/j.biomaterials.2007.06.023 Papadimitropoulos, 2007, Kinetics of in vivo bone deposition by bone marrow stromal cells within a resorbable porous calcium phosphate scaffold: an X-ray computed microtomography study, Biotechnol Bioeng, 98, 271, 10.1002/bit.21418 Friedman, 1998, Bone source hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction, J Biomed Mater Res, 43, 428, 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0 Thein-Han, 2011, Collagen-calcium phosphate cement scaffolds seeded with umbilical cord stem cells for bone tissue engineering, Tissue Eng Part A, 17, 2943, 10.1089/ten.tea.2010.0674 Kim, 2007, A poly(lactide-co-glycolide)/hydroxyapatite composite scaffold with enhanced osteoconductivity, J Biomed Mater Res A, 80, 206, 10.1002/jbm.a.30836 Costantino, 2002, Bone healing and bone substitutes, Facial Plast Surg FPS, 18, 13, 10.1055/s-2002-19823 Wikesjö, 2003, Periodontal repair in dogs: a bioabsorbable calcium carbonate coral implant enhances space provision for alveolar bone regeneration in conjunction with guided tissue regeneration, J Periodontol, 74, 957, 10.1902/jop.2003.74.7.957 Polimeni, 2004, Prognostic factors for alveolar regeneration: effect of a space-providing biomaterial on guided tissue regeneration, J Clin Periodontol, 31, 725, 10.1111/j.1600-051X.2004.00542.x Chen, 2002, Scaffold design for tissue engineering, Macromol Biosci, 2, 67, 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F Ji, 2006, Electrospun three-dimensional hyaluronic acid nanofibrous scaffolds, Biomaterials, 27, 3782, 10.1016/j.biomaterials.2006.02.037 Piskin, 1995, Biodegradable polymers as biomaterials, J Biomater Sci Polym Ed, 6, 775, 10.1163/156856295X00175 Liu, 2004, Polymeric scaffolds for bone tissue engineering, Ann Biomed Eng, 32, 477, 10.1023/B:ABME.0000017544.36001.8e Ahmad, 2008, Outcomes and complications based on experience with resorbable plates in pediatric craniosynostosis patients, J Craniofac Surg, 19, 855, 10.1097/SCS.0b013e31816ae358 Yusop, 2012, Porous biodegradable metals for hard tissue scaffolds: a review, Int J Biomater, 2012, 641430, 10.1155/2012/641430 Lee, 2001, Molded porous poly (l-lactide) membranes for guided bone regeneration with enhanced effects by controlled growth factor release, J Biomed Mater Res, 55, 295, 10.1002/1097-4636(20010605)55:3<295::AID-JBM1017>3.0.CO;2-W Kang, 2012, Effects of co-culturing BMSCs and auricular chondrocytes on the elastic modulus and hypertrophy of tissue engineered cartilage, Biomaterials, 33, 4535, 10.1016/j.biomaterials.2012.03.019 Yokoya, 2008, Tendon-bone insertion repair and regeneration using polyglycolic acid sheet in the rabbit rotator cuff injury model, Am J Sports Med, 36, 1298, 10.1177/0363546508314416 Sedrakyan, 2006, Tissue engineering of a small hand phalanx with a porously casted polylactic acid–polyglycolic acid copolymer, Tissue Eng, 12, 2675, 10.1089/ten.2006.12.2675 Mooney, 1996, Stabilized polyglycolic acid fibre-based tubes for tissue engineering, Biomaterials, 17, 115, 10.1016/0142-9612(96)85756-5 Ishaug, 1997, Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds, J Biomed Mater Res, 36, 17, 10.1002/(SICI)1097-4636(199707)36:1<17::AID-JBM3>3.0.CO;2-O Ishaug-Riley, 1997, J Biomed Mater Res, 36, 1, 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P Ca, 1994, Bone and cartilage reconstruction with tissue engineering approaches, Otolaryngol Clin North Am, 27, 263, 10.1016/S0030-6665(20)30727-1 Gentile, 2014, An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering, Int J Mol Sci, 15, 3640, 10.3390/ijms15033640 Pan, 2012, Poly(lactide-co-glycolide) porous scaffolds for tissue engineering and regenerative medicine, Interface Focus, 2, 366, 10.1098/rsfs.2011.0123 Henslee, 2012, Development of a biodegradable bone cement for craniofacial applications, J Biomed Mater Res A, 100A, 2252 Hedberg, 2005, In vivo degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds, Biomaterials, 26, 4616, 10.1016/j.biomaterials.2004.11.039 Mistry, 2010, In vivo bone biocompatibility and degradation of porous fumarate-based polymer/alumoxane nanocomposites for bone tissue engineering, J Biomed Mater Res A, 92, 451 Timmer, 2003, In vitro degradation of polymeric networks of poly(propylene fumarate) and the crosslinking macromer poly(propylene fumarate)-diacrylate, Biomaterials, 24, 571, 10.1016/S0142-9612(02)00368-X Peter, 1998, In vivo degradation of a poly(propylene fumarate)/β-tricalcium phosphate injectable composite scaffold, J Biomed Mater Res, 41, 1, 10.1002/(SICI)1097-4636(199807)41:1<1::AID-JBM1>3.0.CO;2-N Fisher, 2002, Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model, J Biomed Mater Res, 59, 547, 10.1002/jbm.1268 Kim, 2009, Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on cross-linked poly(propylene fumarate) disks, Biomacromolecules, 10, 1810, 10.1021/bm900240k Fisher, 2001, Synthesis and properties of photocross-linked poly(propylene fumarate) scaffolds, J Biomater Sci Polym Ed, 12, 673, 10.1163/156856201316883476 Chu, 2007, Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2, Biomaterials, 28, 459, 10.1016/j.biomaterials.2006.09.004 Henslee, 2011, Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects, Acta Biomater, 7, 3627, 10.1016/j.actbio.2011.06.043 Peter, 1999, Crosslinking characteristics of an injectable poly(propylene fumarate)/β-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement, J Biomed Mater Res, 44, 314, 10.1002/(SICI)1097-4636(19990305)44:3<314::AID-JBM10>3.0.CO;2-W Yan, 2011, Cross-linking characteristics and mechanical properties of an injectable biomaterial composed of polypropylene fumarate and polycaprolactone co-polymer, J Biomater Sci Polym Ed, 22, 489, 10.1163/092050610X487765 Becker, 2015, Nanocomposite bone scaffolds based on biodegradable polymers and hydroxyapatite, J Biomed Mater Res A, 103, 2549, 10.1002/jbm.a.35391 Ng, 2001, Evaluation of ultra-thin poly(ε-caprolactone) films for tissue-engineered skin, Tissue Eng, 7, 441, 10.1089/10763270152436490 Elfick, 2002, Poly(ε-caprolactone) as a potential material for a temporary joint spacer, Biomaterials, 23, 4463, 10.1016/S0142-9612(02)00163-1 Kweon, 2003, A novel degradable polycaprolactone networks for tissue engineering, Biomaterials, 24, 801, 10.1016/S0142-9612(02)00370-8 Li, 2010, Enhancement of bone formation by BMP-7 transduced MSCs on biomimetic nano-hydroxyapatite/polyamide composite scaffolds in repair of mandibular defects, J Biomed Mater Res A, 95A, 973, 10.1002/jbm.a.32926 Staiger, 2006, Magnesium and its alloys as orthopedic biomaterials: a review, Biomaterials, 27, 1728, 10.1016/j.biomaterials.2005.10.003 Di Mario, 2004, Drug-eluting bioabsorbable magnesium stent, J Interv Cardiol, 17, 391, 10.1111/j.1540-8183.2004.04081.x Peeters, 2005, Preliminary results after application of absorbable metal stents in patients with critical limb ischemia, J Endovasc Ther, 12, 1, 10.1583/04-1349R.1 Witte, 2005, In vivo corrosion of four magnesium alloys and the associated bone response, Biomaterials, 26, 3557, 10.1016/j.biomaterials.2004.09.049 Waksman, 2006, Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries, Catheter Cardiovasc Interv, 68, 607, 10.1002/ccd.20727 Hänzi, 2009, Design strategy for microalloyed ultra-ductile magnesium alloys for medical applications, Mater Sci Forum, 618–619, 75, 10.4028/www.scientific.net/MSF.618-619.75 Zhang, 2008, Microstructure, mechanical properties and bio-corrosion properties of Mg–Zn–Mn–Ca alloy for biomedical application, Mater Sci Eng A, 497, 111, 10.1016/j.msea.2008.06.019 Li, 2008, The development of binary Mg–Ca alloys for use as biodegradable materials within bone, Biomaterials, 29, 1329, 10.1016/j.biomaterials.2007.12.021 Peuster, 2001, A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal—results 6–18 months after implantation into New Zealand white rabbits, Heart, 86, 563, 10.1136/heart.86.5.563 Peuster, 2006, Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta, Biomaterials, 27, 4955, 10.1016/j.biomaterials.2006.05.029 Hermawan, 2008, Iron–manganese: new class of metallic degradable biomaterials prepared by powder metallurgy, Powder Metall, 51, 38, 10.1179/174329008X284868 Schinhammer, 2010, Design strategy for biodegradable Fe-based alloys for medical applications, Acta Biomater, 6, 1705, 10.1016/j.actbio.2009.07.039 Farack, 2011, The effect of perfusion culture on proliferation and differentiation of human mesenchymal stem cells on biocorrodible bone replacement material, Mater Sci Eng B, 176, 1767, 10.1016/j.mseb.2011.06.004 Zhuang, 2008, Preparation, mechanical properties and in vitro biodegradation of porous magnesium scaffolds, Mater Sci Eng C, 28, 1462, 10.1016/j.msec.2008.04.001 Wen, 2004, Compressibility of porous magnesium foam: dependency on porosity and pore size, Mater Lett, 58, 357, 10.1016/S0167-577X(03)00500-7 Tran, 2011, Increased osteoblast functions in the presence of hydroxyapatite-coated iron oxide nanoparticles, Acta Biomater, 7, 1298, 10.1016/j.actbio.2010.10.004 Ricci, 2012, Three-dimensional printing of bone repair and replacement materials: impact on craniofacial surgery, J Craniofac Surg, 23, 304, 10.1097/SCS.0b013e318241dc6e Shie, 2012, Effects of altering the Si/Ca molar ratio of a calcium silicate cement on in vitro cell attachment, Int Endod J, 45, 337, 10.1111/j.1365-2591.2011.01981.x Ni, 2006, A novel bioactive porous CaSiO3 scaffold for bone tissue engineering, J Biomed Mater Res A, 76A, 196, 10.1002/jbm.a.30525 Wang, 2013, Osteogenesis and angiogenesis induced by porous β-CaSiO3/PDLGA composite scaffold via activation of AMPK/ERK1/2 and PI3K/Akt pathways, Biomaterials, 34, 64, 10.1016/j.biomaterials.2012.09.021 Sun, 2009, Influences of ionic dissolution products of dicalcium silicate coating on osteoblastic proliferation, differentiation and gene expression, Acta Biomater, 5, 1284, 10.1016/j.actbio.2008.10.011 Gomes, 2010, Thorough analysis of silicon substitution in biphasic calcium phosphate bioceramics: a multi-technique study, Acta Biomater, 6, 3264, 10.1016/j.actbio.2010.02.034 Reid, 2006, Synthesis and characterization of single-phase silicon-substituted α-tricalcium phosphate, Biomaterials, 27, 2916, 10.1016/j.biomaterials.2006.01.007 Li, 2014, Silicate bioceramics enhanced vascularization and osteogenesis through stimulating interactions between endothelia cells and bone marrow stromal cells, Biomaterials, 35, 3803, 10.1016/j.biomaterials.2014.01.039 Wu, 2011, CaSiO3 microstructure modulating the in vitro and in vivo bioactivity of poly(lactide-co-glycolide) microspheres, J Biomed Mater Res A, 98A, 122, 10.1002/jbm.a.33092 Li, 2009, Effects of wollastonite on proliferation and differentiation of human bone marrow-derived stromal cells in PHBV/wollastonite composite scaffolds, J Biomater Appl, 24, 231, 10.1177/0885328208096043 Li, 2004, Fabrication and characterization of bioactive wollastonite/PHBV composite scaffolds, Biomaterials, 25, 5473, 10.1016/j.biomaterials.2003.12.052 Gandolfi, 2010, Apatite formation on bioactive calcium-silicate cements for dentistry affects surface topography and human marrow stromal cells proliferation, Dent Mater, 26, 974, 10.1016/j.dental.2010.06.002 Ding, 2010, Osteogenic differentiation and immune response of human bone-marrow-derived mesenchymal stem cells on injectable calcium-silicate-based bone grafts, Tissue Eng Part A, 16, 2343, 10.1089/ten.tea.2009.0749 Li, 2013, Stimulation of proangiogenesis by calcium silicate bioactive ceramic, Acta Biomater, 9, 5379, 10.1016/j.actbio.2012.10.019 Zhai, 2013, Stimulatory effects of the ionic products from Ca–Mg–Si bioceramics on both osteogenesis and angiogenesis in vitro, Acta Biomater, 9, 8004, 10.1016/j.actbio.2013.04.024 Wu, 2013, A review of bioactive silicate ceramics, Biomed Mater Bristol Engl, 8, 032001, 10.1088/1748-6041/8/3/032001 Li, 2004, Preparation and characterization of bioactive and biodegradable wollastonite/poly(d,l-lactic acid) composite scaffolds, J Mater Sci Mater Med, 15, 1089, 10.1023/B:JMSM.0000046390.09540.c2 Li, 2005, pH-compensation effect of bioactive inorganic fillers on the degradation of PLGA, Compos Sci Technol, 65, 2226, 10.1016/j.compscitech.2005.04.051 Van Vlierberghe, 2011, Biopolymer-based hydrogels as scaffolds for tissue engineering applications: a review, Biomacromolecules, 12, 1387, 10.1021/bm200083n Ni, 2014, Injectable thermosensitive PEG–PCL–PEG hydrogel/acellular bone matrix composite for bone regeneration in cranial defects, Biomaterials, 35, 236, 10.1016/j.biomaterials.2013.10.016 He, 2008, In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery, J Control Release, 127, 189, 10.1016/j.jconrel.2008.01.005 Kavanagh, 2004, Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems, Pharmacol Ther, 102, 1, 10.1016/j.pharmthera.2003.01.001 Ganta, 2008, A review of stimuli-responsive nanocarriers for drug and gene delivery, J Control Release, 126, 187, 10.1016/j.jconrel.2007.12.017 Brun-Graeppi, 2011, Cell microcarriers and microcapsules of stimuli-responsive polymers, J Control Release, 149, 209, 10.1016/j.jconrel.2010.09.023 Cellesi, 2012, Thermoresponsive hydrogels for cellular delivery, Ther Deliv, 3, 1395, 10.4155/tde.12.114 Klouda, 2008, Thermoresponsive hydrogels in biomedical applications, Eur J Pharm Biopharm, 68, 34, 10.1016/j.ejpb.2007.02.025 Jasionowski, 2004, Thermally-reversible gel for 3-D cell culture of chondrocytes, J Mater Sci Mater Med, 15, 575, 10.1023/B:JMSM.0000026379.24560.a2 Wu, 1997, Light scattering study of spherical poly(N-isopropylacrylamide) microgels, J Macromol Sci Part B, 36, 345, 10.1080/00222349708212388 Otake, 1990, Thermal analysis of the volume phase transition with N-isopropylacrylamide gels, Macromolecules, 23, 283, 10.1021/ma00203a049 Hacker, 2008, Synthesis and characterization of injectable, thermally and chemically gelable, amphiphilic poly(n-isopropylacrylamide)-based macromers, Biomacromolecules, 9, 1558, 10.1021/bm8000414 Lau, 2011, Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine, Expert Opin Biol Ther, 11, 189, 10.1517/14712598.2011.546338 Van Lith, 2014, Engineering biodegradable polyester elastomers with antioxidant properties to attenuate oxidative stress in tissues, Biomaterials, 35, 8113, 10.1016/j.biomaterials.2014.06.004 Diniz, 2015, Pluronic F-127 hydrogel as a promising scaffold for encapsulation of dental-derived mesenchymal stem cells, J Mater Sci Mater Med, 26, 153, 10.1007/s10856-015-5493-4 Hennink, 2002, Novel crosslinking methods to design hydrogels, Adv Drug Deliv Rev, 54, 13, 10.1016/S0169-409X(01)00240-X Lee, 2007, Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering, Adv Drug Deliv Rev, 59, 339, 10.1016/j.addr.2007.03.016 Shah, 2014, Materials used in cranioplasty: a history and analysis, Neurosurg Focus, 36, E19, 10.3171/2014.2.FOCUS13561 Kretlow, 2009, Injectable biomaterials for regenerating complex craniofacial tissues, Adv Mater, 21, 3368, 10.1002/adma.200802009 Fu, 2012, In vivo biocompatibility and osteogenesis of electrospun poly(ε-caprolactone)–poly(ethylene glycol)–poly(ε-caprolactone)/nano-hydroxyapatite composite scaffold, Biomaterials, 33, 8363, 10.1016/j.biomaterials.2012.08.023 Fu, 2012, Injectable and thermo-sensitive PEG-PCL-PEG copolymer/collagen/n-HA hydrogel composite for guided bone regeneration, Biomaterials, 33, 4801, 10.1016/j.biomaterials.2012.03.040 Wang, 2013, Hybrid hydroxyapatite nanoparticle colloidal gels are injectable fillers for bone tissue engineering, Tissue Eng Part A, 19, 2586, 10.1089/ten.tea.2013.0075 Kang, 2008, Apatite-coated poly(lactic-co-glycolic acid) microspheres as an injectable scaffold for bone tissue engineering, J Biomed Mater Res A, 85A, 747, 10.1002/jbm.a.31572 Shi, 2008, Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications, Pharm Res, 26, 422, 10.1007/s11095-008-9759-0 Woodruff, 2010, The return of a forgotten polymer—polycaprolactone in the 21st century, Prog Polym Sci, 35, 1217, 10.1016/j.progpolymsci.2010.04.002 Zakaria, 2013, Nanophase hydroxyapatite as a biomaterial in advanced hard tissue engineering: a review, Tissue Eng Part B Rev, 19, 431, 10.1089/ten.teb.2012.0624 Ripamonti, 2011, Biomimetic matrices self-initiating the induction of bone formation, J Craniofac Surg, 22, 1859, 10.1097/SCS.0b013e31822e83fe Wu, 2009, Extracellular calcium increases CXCR4 expression on bone marrow-derived cells and enhances pro-angiogenesis therapy, J Cell Mol Med, 13, 3764, 10.1111/j.1582-4934.2009.00691.x